InvestorsHub Logo
Followers 0
Posts 42
Boards Moderated 0
Alias Born 07/23/2013

Re: None

Tuesday, 10/04/2016 6:43:37 AM

Tuesday, October 04, 2016 6:43:37 AM

Post# of 12450
If they start the P2 trial on Montelukast In January as promised that will get attention. But other catalysts to look out for are three ANDA filings they promised in 2016 now pushed back to early 2017. They are Rizaport, Taladafil and Par 2 drug. Also possible resolution of legal action over Suboxone.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IGXT News